March 3, 2022 Comments Off on New patent expiration for Bayer Hlthcare drug SAFYRAL Posted in: Uncategorized
Annual Drug Patent Expirations for SAFYRAL Safyral is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for Bayer Hlthcare drug SAFYRAL appeared fir…
March 3, 2022 Comments Off on New patent expiration for Astrazeneca Ab drug BYDUREON BCISE Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent expiration for Astrazeneca Ab drug BYDUREON BCIS…
